Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > SWR&D Issued Patent for Nano-Scaled Constructs

Abstract:
Lawton-based SWR&D, Inc. has been issued a new patent related to their chemotherpeutic delivery technology. The patent, entitled "Magnetically Responsive Nanoparticle Therapeutic Constructs and Methods of Making and Using" involves the bonding of a therapeutic molecule to a magnetic nanoparticle. This construct is introduced into the body then driven to the site within a focused magnetic field.

SWR&D Issued Patent for Nano-Scaled Constructs

Lawton, OK | Posted on March 30th, 2014

"Site-specific delivery of therapeutics has a host of advantages of traditional delivery methods," says Clinton Herring, President and CEO of SWR&D, Inc. "For example, in the treatment of cancer, this technology allows more chemotherapeutic to be delivered to the site while introducing less chemotherapeutic into the body. By doing so, no healthy tissue is affected and patients do not suffer the side effects associated with traditional chemotherapy."

Herring points out that, while the primary focus of this technology has been in the area of chemotherapy, it is being applied to other forms of therapy where site-specific delivery of therapeutics is desired. "This technology has caught the interest of other researchers who are exploring other applications. In fact, we are currently in the process of negotiating a non-exclusive license with a research organization in Oklahoma City."

Other patents related to this technology owned by SWR&D, Inc. include; Device for Moving Magnetic Nanoparticles Through Tissue and Delivery of Bioactive Substances to Target Cells.

####

For more information, please click here

Contacts:
Dennis Donaldson
Senior Vice President
SWR&D, Inc.
102 NE 20th
Lawton, OK 73507
V: 405.706.9687

Copyright © SWR&D, Inc.

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Sopping up proteins with thermosponges: Researchers develop novel nanoparticle platform that proves effective in delivering protein-based drugs October 22nd, 2014

Brookhaven Lab Launches Computational Science Initiative:Leveraging computational science expertise and investments across the Laboratory to tackle "big data" challenges October 22nd, 2014

Bipolar Disorder Discovery at the Nano Level: Tiny structures found in brain synapses help scientists better understand disorder October 22nd, 2014

NIST offers electronics industry 2 ways to snoop on self-organizing molecules October 22nd, 2014

Nanomedicine

Sopping up proteins with thermosponges: Researchers develop novel nanoparticle platform that proves effective in delivering protein-based drugs October 22nd, 2014

Bipolar Disorder Discovery at the Nano Level: Tiny structures found in brain synapses help scientists better understand disorder October 22nd, 2014

Journal Nanotechnology Progress International (JONPI), 2014, Volume 5, Issue 1, pp 1-24 October 22nd, 2014

TARA Biosystems and Harris & Harris Group Form Company to Improve Safety and Efficacy of New Therapies October 22nd, 2014

Announcements

NanoTechnology for Defense (NT4D) October 22nd, 2014

Mechanism behind nature's sparkles revealed October 22nd, 2014

TARA Biosystems and Harris & Harris Group Form Company to Improve Safety and Efficacy of New Therapies October 22nd, 2014

Researchers patent a nanofluid that improves heat conductivity October 22nd, 2014

Patents/IP/Tech Transfer/Licensing

Researchers patent a nanofluid that improves heat conductivity October 22nd, 2014

Nanodevices for clinical diagnostic with potential for the international market: The development is based on optical principles and provides precision and allows saving vital time for the patient October 15th, 2014

Aculon Receives Patent for Application of Enhanced Bonding Layers on Titanium October 9th, 2014

harmaEngine will join Nanobiotix’ pivotal trial for NBTXR3 in Soft Tissue Sarcoma to accelerate its development in Asia-Pacific: PharmaEngine to make milestone payment to Nanobiotix in October 2014 to recognize the value created October 8th, 2014

NanoNews-Digest
The latest news from around the world, FREE





  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE